Cite
HARVARD Citation
Heinze, K. et al. (2022). Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas. Journal of pathology. 256 (4), pp. 388-401. [Online].